52 related articles for article (PubMed ID: 1409415)
1. Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.
Suter L; Bröcker EB; Brüggen J; Ruiter DJ; Sorg C
Cancer Immunol Immunother; 1983; 16(1):53-8. PubMed ID: 6556951
[TBL] [Abstract][Full Text] [Related]
2. Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention.
Sigalotti L; Covre A; Nicolay HJ; Coral S; Maio M
Cancer Immunol Immunother; 2010 Mar; 59(3):487-8. PubMed ID: 19862522
[No Abstract] [Full Text] [Related]
3. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
[TBL] [Abstract][Full Text] [Related]
4. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
Collina G
Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
[No Abstract] [Full Text] [Related]
5. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
6. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
Maeda K; Maeda K; Jimbow K
J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
[TBL] [Abstract][Full Text] [Related]
7. Antigens associated with tumor progression in melanocytic neoplasia.
Elder DE; Herlyn M
Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
[No Abstract] [Full Text] [Related]
8. Update on immunohistochemistry in melanocytic lesions.
Ferringer T
Dermatol Clin; 2012 Oct; 30(4):567-79, v. PubMed ID: 23021046
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
10. [Morphological changes in melanocytic nevi induced by exogenous factors].
Tronnier M; Alexander M; Neitmann M; Brinckmann J; Wolff HH
Hautarzt; 2000 Aug; 51(8):561-6. PubMed ID: 10997310
[TBL] [Abstract][Full Text] [Related]
11. [Reporting melanocytic lesions: the form, substance, and the void].
Urso C
Pathologica; 2001 Jun; 93(3):253-7. PubMed ID: 11433624
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]